• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

In unique deal, Amgen offering full refund to Harvard Pilgrim if $14,000 drug fails
Amgen is so sure its cholesterol-lowering drug Repatha works that it has agreed to fully cover the costs for Harvard Pilgrim patients taking the drug if they land in the hospital with a heart attack or stroke, in a deal the insurer calls groundbreaking. Harvard Pilgrim Health Care announced the broadened agreement with Amgen (Nasdaq: AMGN) on Tuesday, saying the contract guarantees that patients properly taking the drug for at least six months will receive a full reimbursement of their hospital…
Source: bizjournals.com Health Care:Physician Practices headlines - May 2, 2017 Category: American Health Authors: Jessica Bartlett Source Type: news

Battelle, AmplifyBio, Andelyn team up NIH contract targeting stroke, neurological disease
“If we can be part of bringing something like that to market – I think that’s a pretty big deal."
Source: bizjournals.com Health Care:Physician Practices headlines - January 10, 2023 Category: American Health Authors: Carrie Ghose Source Type: news